Speaker illustration

Doctor Al Bellibas

The Medicines Company, Parsippany (United States of America)

Body weight does not affect systemic PK exposure parameters of MDCO-216 in healthy volunteers and CAD patients

Event: ESC Congress 2016

Topic: CAD and comorbidities

Session: Comorbidities and risk for CAD


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb